1Markel A, Meissner MH, Manzo RA, et al. Deep venous thrombosis: rate of spontaneous lysis and thrombus extension. Int Angiol,2003,22 (4): 376 -382
2Kearon C,Julian JA, Math M, et al. Noninvasive diagnosis of deep vein thrombosis. Ann Intern Med, 1998,128(8) :663-677
3Quinlan DJ, Alikhan R, Gishen P, et al. Variations in lower limb yenous anatomy:implications for US diagnosis of deep vein thrombosis. Radiology, 2003,228 (2): 443-448
5Birck R, Krzossok S, Markowetz F, et al. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet, 2003, 362(9384): 598-603
6Brown DB, Pappas JA, Vedantham S, et al. Gadolinium, carbon dioxide,and iodinated contrast material for planning inferior vena cava filter placement: a prospective trial. J Vasc Interv Radiol,2003,14(8): 1017-1022
7Fraser DG,Moody AR,Martel A,et al. Re-evaluation of iliac compression syndrome using magnetic resonance imaging in patients with acute deep venous thromboses. J Vasc Surg, 2004, 40 (4):604-611
8Bates SM, Lister-James J, Julian JA, et al. Imaging characteristics of a novel technetium Tc 99m-labeled platelet glycoprotein Ⅱ b/Ⅲ a receptor antagonist in patients with acute deep vein thrombosis or a history of deep vein thrombosis. Arch Intern Med,2003,163(4):452-456
9Birck R, Krzossok S, Markowetz F, et al. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet, 2003, 362(9384): 598-603.
10Brown DB, Pappas JA, Vedantham S, et al. Gadolinium, carbon dioxide,and iodinated contrast material for planning inferior vena cava filter placement: a prospective trial. J Vasc Interv Radiol,2003,14(8): 1017-1022.
